Guimarães, R.P.; Ribeiro, D.L.; Dos Santos, K.B.; Talarico, C.H.Z.; Godoy, L.D.; Padovan-Neto, F.E.
Phosphodiesterase 10A Inhibition Modulates the Corticostriatal Activity and L-DOPA-Induced Dyskinesia. Pharmaceuticals 2022, 15, 947.
https://doi.org/10.3390/ph15080947
AMA Style
Guimarães RP, Ribeiro DL, Dos Santos KB, Talarico CHZ, Godoy LD, Padovan-Neto FE.
Phosphodiesterase 10A Inhibition Modulates the Corticostriatal Activity and L-DOPA-Induced Dyskinesia. Pharmaceuticals. 2022; 15(8):947.
https://doi.org/10.3390/ph15080947
Chicago/Turabian Style
Guimarães, Rayanne Poletti, Danilo Leandro Ribeiro, Keila Bariotto Dos Santos, Carlos Henrique Zanello Talarico, LÃvea Dornela Godoy, and Fernando E. Padovan-Neto.
2022. "Phosphodiesterase 10A Inhibition Modulates the Corticostriatal Activity and L-DOPA-Induced Dyskinesia" Pharmaceuticals 15, no. 8: 947.
https://doi.org/10.3390/ph15080947
APA Style
Guimarães, R. P., Ribeiro, D. L., Dos Santos, K. B., Talarico, C. H. Z., Godoy, L. D., & Padovan-Neto, F. E.
(2022). Phosphodiesterase 10A Inhibition Modulates the Corticostriatal Activity and L-DOPA-Induced Dyskinesia. Pharmaceuticals, 15(8), 947.
https://doi.org/10.3390/ph15080947
